XTNT
Xtant Medical Holdings, Inc.
Price Chart
Latest Quote
$0.46
-0.00 (-0.91%)
Current Price
| Previous Close | $0.46 |
| Open | $0.46 |
| Day High | $0.47 |
| Day Low | $0.46 |
| Volume | 61,217 |
Stock Information
| Shares Outstanding | 140.26M |
| Total Debt | $15.44M |
| Cash Equivalents | $12.14M |
| Revenue | $121.91M |
| Net Income | $1.83M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $63.95M |
| P/E Ratio | 45.59 |
| EPS (TTM) | $0.01 |
| Exchange | ASE |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $67.16M |
| Sales | $121.91M |
| Income | $1.83M |
| Book/sh | $0.35 |
| Cash/sh | $0.09 |
| Employees | 151 |
Financial Ratios
| Quick Ratio | 1.56 |
| Current Ratio | 3.34 |
| Debt/Eq | 31.76 |
Returns & Margins
| ROA | 2.37% |
| ROE | 3.95% |
| Gross Margin | 62.34% |
| Operating Margin | -14.00% |
| Profit Margin | 1.50% |
Ownership
| Insider Ownership | 13.84% |
| Institutional Ownership | 57.33% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -91.18 |
| PEG | 1.74 |
| P/S | 0.52 |
| P/B | 1.31 |
Analyst Data
| Recommendation | none |
| Target Price | $1.23 |
Technical Indicators
| SMA20 | $0.47 |
| SMA50 | $0.50 |
| SMA200 | $0.63 |
| RSI | 50.00 |
| ATR | 0.0193 |
| Shares Float | 54.10M |
| Short Float | 0.03% |
| Short Ratio | 0.15 |
| Volatility | -0.17 |
| Rel Volume | 0.38 |
Performance History
| Week | +0.00% |
| Month | -20.69% |
| Quarter | -25.81% |
| 6 Months | -23.33% |
| YTD | -38.67% |
| Year | -32.35% |
| 3 Years | -25.81% |
| 5 Years | -68.49% |
| 10 Years | -98.25% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-05 | $0.46 | 62,200 |
| 2026-06-04 | $0.46 | 132,100 |
| 2026-06-03 | $0.46 | 48,400 |
| 2026-06-02 | $0.47 | 144,800 |
| 2026-06-01 | $0.46 | 52,700 |
| 2026-05-29 | $0.46 | 109,700 |
| 2026-05-28 | $0.47 | 181,400 |
| 2026-05-27 | $0.46 | 66,400 |
| 2026-05-26 | $0.46 | 343,100 |
| 2026-05-22 | $0.48 | 129,000 |
| 2026-05-21 | $0.47 | 134,800 |
| 2026-05-20 | $0.47 | 303,900 |
| 2026-05-19 | $0.46 | 83,300 |
| 2026-05-18 | $0.46 | 295,900 |
| 2026-05-15 | $0.46 | 124,100 |
| 2026-05-14 | $0.47 | 145,700 |
| 2026-05-13 | $0.48 | 302,300 |
| 2026-05-12 | $0.50 | 268,700 |
| 2026-05-11 | $0.52 | 97,300 |
| 2026-05-08 | $0.52 | 285,400 |
| 2026-05-07 | $0.57 | 51,600 |
| 2026-05-06 | $0.58 | 96,000 |
About Xtant Medical Holdings, Inc.
Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. It offers OsteoSponge, a natural scaffold for cellular in-growth; OsteoSelect DBM Putty, a moldable demineralized bone matrix; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated and terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor Pro, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, an aseptically processed and viable bone allograft; and nanOss products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier. It also provides sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. In addition, it offers cervical products comprising Spider cervical plating, Streamline OCT system, and CervAlign systems; thoracolumbar products, such as of Axle-X interspinous fusion, Streamline MIS spinal fixation, Streamline TL spinal fixation, and HPS 2.0 hybrid performance systems; Silex sacroiliac joint fusion systems; interbody products comprising Calix for cervical and thoracolumbar applications, Irix-C Cervical and Irix-A lumbar integrated dusion systems, and Fortilink implants; Contact ALP (Anterior Lumbar Plate) System; and interlaminar stabilization products, such as Coflex device for lumbar spinal stenosis; and CoFix implants for back and disc pain. The company is headquartered in Belgrade, Montana.
đ° Latest News
Xtant Medical Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-16T02:05:12Z
Xtant Medical Holdings, Inc. Q1 2026 Earnings Call Summary
Moby âĸ 2026-05-14T00:39:52Z
Xtant Medical Holdings Inc (XTNT) Q1 2026 Earnings Call Highlights: Navigating Challenges and ...
GuruFocus.com âĸ 2026-05-13T23:01:33ZXtant Medical Hldgs Q1 2026 Earnings Call Transcript
Benzinga âĸ 2026-05-13T13:50:53Z
3 Promising Penny Stocks With Market Caps Under $200M
Simply Wall St. âĸ 2026-04-30T18:05:22Z
Xtant Medical Holdings Inc (XTNT) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ...
GuruFocus.com âĸ 2026-03-31T19:01:56ZXtant Medical Holdings, Inc. Q4 2025 Earnings Call Summary
Moby âĸ 2026-03-31T16:47:03Z
Xtant Medical Q4 Earnings Call Highlights
MarketBeat âĸ 2026-03-31T16:08:55Z
3 Promising Penny Stocks With Over $90M Market Cap
Simply Wall St. âĸ 2025-12-09T12:05:19Z
Xtant Medical Holdings Inc (XTNT) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ...
GuruFocus.com âĸ 2025-11-11T21:01:11Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $49,654,000 | $49,051,000 | $35,836,000 | $25,832,000 |
| Cost Of Revenue | $49,654,000 | $49,051,000 | $35,836,000 | $25,832,000 |
| Total Revenue | $133,927,000 | $117,267,000 | $91,303,000 | $57,969,000 |
| Operating Revenue | $133,927,000 | $117,267,000 | $91,303,000 | $57,969,000 |
| Expenses | ||||
| Interest Expense | $3,671,000 | $4,160,000 | $2,938,000 | $1,692,000 |
| Total Expenses | $126,643,000 | $129,341,000 | $101,461,000 | $64,724,000 |
| Other Income Expense | $3,294,000 | $-28,000 | $11,910,000 | - |
| Other Non Operating Income Expenses | $73,000 | $-33,000 | $-49,000 | - |
| Net Non Operating Interest Income Expense | $-3,577,000 | $-4,160,000 | $-2,789,000 | $-1,661,000 |
| Interest Expense Non Operating | $3,671,000 | $4,160,000 | $2,938,000 | $1,692,000 |
| Operating Expense | $76,989,000 | $80,290,000 | $65,625,000 | $38,892,000 |
| Selling And Marketing Expense | $45,512,000 | $49,214,000 | $38,439,000 | $22,515,000 |
| General And Administrative Expense | $29,375,000 | $28,691,000 | $25,850,000 | $15,462,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $4,973,000 | $-16,449,000 | $660,000 | $-8,485,000 |
| Net Interest Income | $-3,577,000 | $-4,160,000 | $-2,789,000 | $-1,661,000 |
| Interest Income | $94,000 | $0 | $149,000 | $31,000 |
| Normalized Income | $2,686,090 | $-16,452,950 | $-8,787,610 | $-8,485,000 |
| Net Income From Continuing And Discontinued Operation | $4,973,000 | $-16,449,000 | $660,000 | $-8,485,000 |
| Total Operating Income As Reported | $7,284,000 | $-12,074,000 | $-10,158,000 | $-6,755,000 |
| Net Income Common Stockholders | $4,973,000 | $-16,449,000 | $660,000 | $-8,485,000 |
| Net Income | $4,973,000 | $-16,449,000 | $660,000 | $-8,485,000 |
| Net Income Including Noncontrolling Interests | $4,973,000 | $-16,449,000 | $660,000 | $-8,485,000 |
| Net Income Continuous Operations | $4,973,000 | $-16,449,000 | $660,000 | $-8,485,000 |
| Pretax Income | $7,001,000 | $-16,262,000 | $-1,037,000 | $-8,416,000 |
| Special Income Charges | $3,281,000 | $0 | $11,694,000 | $0 |
| Interest Income Non Operating | $94,000 | $0 | $149,000 | $31,000 |
| Operating Income | $7,284,000 | $-12,074,000 | $-10,158,000 | $-6,755,000 |
| Gross Profit | $84,273,000 | $68,216,000 | $55,467,000 | $32,137,000 |
| Per Share | ||||
| Diluted EPS | $0.03 | $-0.12 | $0.01 | $-0.09 |
| Basic EPS | $0.04 | $-0.12 | $0.01 | $-0.09 |
| Other | ||||
| Tax Effect Of Unusual Items | $934,090 | $1,050 | $2,511,390 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $12,674,000 | $-7,883,000 | $-6,884,000 | $-5,432,000 |
| Total Unusual Items | $3,221,000 | $5,000 | $11,959,000 | $0 |
| Total Unusual Items Excluding Goodwill | $3,221,000 | $5,000 | $11,959,000 | $0 |
| Reconciled Depreciation | $5,223,000 | $4,224,000 | $3,174,000 | $1,292,000 |
| EBITDA (Bullshit earnings) | $15,895,000 | $-7,878,000 | $5,075,000 | $-5,432,000 |
| EBIT | $10,672,000 | $-12,102,000 | $1,901,000 | $-6,724,000 |
| Diluted Average Shares | $150,042,556 | $133,665,075 | $126,793,318 | $94,085,197 |
| Basic Average Shares | $139,531,791 | $133,665,075 | $119,093,687 | $94,085,197 |
| Diluted NI Availto Com Stockholders | $4,973,000 | $-16,449,000 | $660,000 | $-8,485,000 |
| Tax Provision | $2,028,000 | $187,000 | $-1,697,000 | $69,000 |
| Gain On Sale Of Business | $3,281,000 | $0 | - | - |
| Gain On Sale Of Security | $-60,000 | $5,000 | $265,000 | - |
| Research And Development | $2,102,000 | $2,385,000 | $1,336,000 | $915,000 |
| Selling General And Administration | $74,887,000 | $77,905,000 | $64,289,000 | $37,977,000 |
| Other Gand A | $29,375,000 | $28,691,000 | $25,850,000 | $15,462,000 |
| Restructuring And Mergern Acquisition | - | $0 | $-11,694,000 | $0 |
Fetched: 2026-05-21
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $44,580,000 | $27,305,000 | $33,962,000 | $30,622,000 |
| Total Assets | $94,145,000 | $93,837,000 | $92,612,000 | $60,229,000 |
| Total Non Current Assets | $15,900,000 | $26,721,000 | $27,743,000 | $10,911,000 |
| Other Non Current Assets | $133,000 | $103,000 | $141,000 | $197,000 |
| Goodwill And Other Intangible Assets | $6,373,000 | $15,658,000 | $17,387,000 | $3,549,000 |
| Other Intangible Assets | $299,000 | $8,356,000 | $10,085,000 | $344,000 |
| Current Assets | $78,245,000 | $67,116,000 | $64,869,000 | $49,318,000 |
| Other Current Assets | $2,389,000 | $1,601,000 | $1,330,000 | $673,000 |
| Restricted Cash | $275,000 | $22,000 | $208,000 | $209,000 |
| Inventory | $30,263,000 | $38,634,000 | $36,885,000 | $17,285,000 |
| Receivables | $28,265,000 | $20,660,000 | $20,731,000 | $10,853,000 |
| Notes Receivable | $10,462,000 | $0 | - | - |
| Accounts Receivable | $17,803,000 | $20,660,000 | $20,731,000 | $10,853,000 |
| Allowance For Doubtful Accounts Receivable | $-2,165,000 | $-1,437,000 | $-920,000 | $-515,000 |
| Gross Accounts Receivable | $19,968,000 | $22,097,000 | $21,651,000 | $11,368,000 |
| Cash Cash Equivalents And Short Term Investments | $17,053,000 | $6,199,000 | $5,715,000 | $20,298,000 |
| Cash And Cash Equivalents | $17,053,000 | $6,199,000 | $5,715,000 | $20,298,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Net Debt | $8,330,000 | $27,959,000 | $16,074,000 | - |
| Total Debt | $28,717,000 | $35,143,000 | $23,559,000 | $17,072,000 |
| Long Term Debt And Capital Lease Obligation | $13,703,000 | $22,251,000 | $18,042,000 | $10,840,000 |
| Long Term Debt | $11,026,000 | $22,038,000 | $17,167,000 | $9,687,000 |
| Current Debt And Capital Lease Obligation | $15,014,000 | $12,892,000 | $5,517,000 | $6,232,000 |
| Current Debt | $14,357,000 | $12,120,000 | $4,622,000 | $5,712,000 |
| Other Current Borrowings | $3,500,000 | - | - | $2,333,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $43,192,000 | $50,874,000 | $41,263,000 | $26,058,000 |
| Total Non Current Liabilities Net Minority Interest | $13,708,000 | $22,293,000 | $18,273,000 | $10,840,000 |
| Non Current Deferred Liabilities | $5,000 | $42,000 | $21,000 | $0 |
| Non Current Deferred Taxes Liabilities | $5,000 | $42,000 | $21,000 | $0 |
| Current Liabilities | $29,484,000 | $28,581,000 | $22,990,000 | $15,218,000 |
| Payables And Accrued Expenses | $14,470,000 | $15,689,000 | $17,473,000 | $8,986,000 |
| Payables | $12,753,000 | $13,886,000 | $15,944,000 | $7,954,000 |
| Other Payable | $6,726,000 | $5,565,000 | $8,890,000 | $4,464,000 |
| Total Tax Payable | $2,183,000 | $403,000 | - | - |
| Accounts Payable | $3,844,000 | $7,918,000 | $7,054,000 | $3,490,000 |
| Equity | ||||
| Common Stock Equity | $50,953,000 | $42,963,000 | $51,349,000 | $34,171,000 |
| Total Equity Gross Minority Interest | $50,953,000 | $42,963,000 | $51,349,000 | $34,171,000 |
| Stockholders Equity | $50,953,000 | $42,963,000 | $51,349,000 | $34,171,000 |
| Gains Losses Not Affecting Retained Earnings | $0 | $-316,000 | $29,000 | $0 |
| Retained Earnings | $-254,486,000 | $-259,459,000 | $-243,010,000 | $-243,670,000 |
| Other Equity Adjustments | - | $-316,000 | $29,000 | - |
| Other | ||||
| Ordinary Shares Number | $140,039,557 | $139,045,664 | $130,180,031 | $108,874,803 |
| Share Issued | $140,039,557 | $139,045,664 | $130,180,031 | $108,874,803 |
| Tangible Book Value | $44,580,000 | $27,305,000 | $33,962,000 | $30,622,000 |
| Invested Capital | $76,336,000 | $77,121,000 | $73,138,000 | $49,570,000 |
| Working Capital | $48,761,000 | $38,535,000 | $41,879,000 | $34,100,000 |
| Capital Lease Obligations | $3,334,000 | $985,000 | $1,770,000 | $1,673,000 |
| Total Capitalization | $61,979,000 | $65,001,000 | $68,516,000 | $43,858,000 |
| Additional Paid In Capital | $305,439,000 | $302,738,000 | $294,330,000 | $277,841,000 |
| Capital Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $2,677,000 | $213,000 | $875,000 | $1,153,000 |
| Current Capital Lease Obligation | $657,000 | $772,000 | $895,000 | $520,000 |
| Line Of Credit | $10,857,000 | $12,120,000 | $4,622,000 | $3,379,000 |
| Current Accrued Expenses | $1,717,000 | $1,803,000 | $1,529,000 | $1,032,000 |
| Goodwill | $6,074,000 | $7,302,000 | $7,302,000 | $3,205,000 |
| Net PPE | $9,394,000 | $10,960,000 | $10,215,000 | $7,165,000 |
| Accumulated Depreciation | $-22,207,000 | $-19,837,000 | $-19,680,000 | $-17,964,000 |
| Gross PPE | $31,601,000 | $30,797,000 | $29,895,000 | $25,129,000 |
| Leases | $4,483,000 | $4,356,000 | $4,347,000 | $4,105,000 |
| Other Properties | $25,505,000 | $24,826,000 | $23,988,000 | $19,751,000 |
| Machinery Furniture Equipment | $1,613,000 | $1,615,000 | $1,560,000 | $1,273,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $19,775,000 | $29,200,000 | $28,054,000 | $10,859,000 |
| Work In Process | $4,799,000 | $2,812,000 | $1,562,000 | $798,000 |
| Raw Materials | $5,689,000 | $6,622,000 | $7,269,000 | $5,628,000 |
| Non Current Accrued Expenses | - | $0 | $210,000 | $0 |
Fetched: 2026-05-21
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $10,164,000 | $-16,009,000 | $-10,971,000 | $-7,105,000 |
| Operating Activities | ||||
| Operating Cash Flow | $12,546,000 | $-11,896,000 | $-9,515,000 | $-5,341,000 |
| Cash Flow From Continuing Operating Activities | $12,546,000 | $-11,896,000 | $-9,515,000 | $-5,341,000 |
| Operating Gains Losses | $-3,030,000 | $-264,000 | $-115,000 | $-93,000 |
| Investing Activities | ||||
| Capital Expenditure | $-2,382,000 | $-4,113,000 | $-1,456,000 | $-1,764,000 |
| Investing Cash Flow | $7,899,000 | $-3,730,000 | $-24,784,000 | $-1,559,000 |
| Cash Flow From Continuing Investing Activities | $7,899,000 | $-3,730,000 | $-24,784,000 | $-1,559,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-65,000 | - | - | - |
| Financing Cash Flow | $-9,570,000 | $16,073,000 | $19,691,000 | $9,020,000 |
| Cash Flow From Continuing Financing Activities | $-9,570,000 | $16,073,000 | $19,691,000 | $9,020,000 |
| Net Other Financing Charges | $-175,000 | $-829,000 | $-500,000 | - |
| Net Common Stock Issuance | $-65,000 | $4,456,000 | $14,011,000 | $9,311,000 |
| Issuance Of Capital Stock | - | $4,456,000 | $14,011,000 | $9,311,000 |
| Common Stock Issuance | - | $4,456,000 | $14,011,000 | $9,311,000 |
| Other | ||||
| Repayment Of Debt | $-109,396,000 | $-105,207,000 | $-77,039,000 | $-54,520,000 |
| Issuance Of Debt | $100,066,000 | $117,640,000 | $83,219,000 | $54,229,000 |
| End Cash Position | $17,328,000 | $6,221,000 | $5,923,000 | $20,507,000 |
| Beginning Cash Position | $6,221,000 | $5,923,000 | $20,507,000 | $18,387,000 |
| Effect Of Exchange Rate Changes | $232,000 | $-149,000 | $24,000 | $0 |
| Changes In Cash | $10,875,000 | $447,000 | $-14,608,000 | $2,120,000 |
| Proceeds From Stock Option Exercised | $0 | $13,000 | $0 | - |
| Common Stock Payments | $-65,000 | - | - | - |
| Net Issuance Payments Of Debt | $-9,330,000 | $12,433,000 | $6,180,000 | $-291,000 |
| Net Short Term Debt Issuance | $-1,263,000 | $7,498,000 | $1,243,000 | $-241,000 |
| Short Term Debt Payments | $-101,329,000 | $-105,142,000 | $-76,976,000 | $-54,470,000 |
| Short Term Debt Issuance | $100,066,000 | $112,640,000 | $78,219,000 | $54,229,000 |
| Net Long Term Debt Issuance | $-8,067,000 | $4,935,000 | $4,937,000 | $-50,000 |
| Long Term Debt Payments | $-8,067,000 | $-65,000 | $-63,000 | $-50,000 |
| Long Term Debt Issuance | $0 | $5,000,000 | $5,000,000 | $0 |
| Net Business Purchase And Sale | $10,049,000 | $0 | $-23,503,000 | $0 |
| Sale Of Business | $10,049,000 | $0 | - | - |
| Net PPE Purchase And Sale | $-2,150,000 | $-3,730,000 | $-1,281,000 | $-1,559,000 |
| Sale Of PPE | $232,000 | $383,000 | $175,000 | $205,000 |
| Purchase Of PPE | $-2,382,000 | $-4,113,000 | $-1,456,000 | $-1,764,000 |
| Change In Working Capital | $-3,046,000 | $-5,349,000 | $-3,634,000 | $-2,811,000 |
| Change In Payables And Accrued Expense | $1,081,000 | $-1,882,000 | $6,768,000 | $2,021,000 |
| Change In Accrued Expense | $4,198,000 | $-2,915,000 | $3,788,000 | $1,146,000 |
| Change In Payable | $-3,117,000 | $1,033,000 | $2,980,000 | $875,000 |
| Change In Account Payable | $-3,117,000 | $1,033,000 | $2,980,000 | $875,000 |
| Change In Prepaid Assets | $-1,537,000 | $-218,000 | $220,000 | $261,000 |
| Change In Inventory | $-1,999,000 | $-2,494,000 | $-1,886,000 | $-1,152,000 |
| Change In Receivables | $-591,000 | $-755,000 | $-8,736,000 | $-3,941,000 |
| Changes In Account Receivables | $-591,000 | $-755,000 | $-8,736,000 | $-3,941,000 |
| Other Non Cash Items | $461,000 | $517,000 | $-11,292,000 | $237,000 |
| Stock Based Compensation | $2,892,000 | $4,117,000 | $2,739,000 | $2,464,000 |
| Provisionand Write Offof Assets | $5,073,000 | $1,308,000 | $854,000 | $2,055,000 |
| Depreciation Amortization Depletion | $5,223,000 | $4,224,000 | $3,174,000 | $1,292,000 |
| Depreciation And Amortization | $5,223,000 | $4,224,000 | $3,174,000 | $1,292,000 |
| Gain Loss On Sale Of PPE | $251,000 | $-264,000 | $-115,000 | $-93,000 |
| Gain Loss On Sale Of Business | $-3,281,000 | $0 | - | - |
| Net Income From Continuing Operations | $4,973,000 | $-16,449,000 | $660,000 | $-8,485,000 |
| Interest Paid Supplemental Data | - | $3,638,000 | $2,552,000 | $1,454,000 |
| Purchase Of Business | - | $0 | $-23,503,000 | $0 |
| Deferred Tax | - | $21,000 | $-1,901,000 | $0 |
| Deferred Income Tax | - | $21,000 | $-1,901,000 | $0 |
Fetched: 2026-05-21